1.
Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET. Mediterr J Hematol Infect Dis [Internet]. 2012 Jun. 19 [cited 2026 May 24];4(1):e2012041. Available from: https://www.mjhid.org/mjhid/article/view/2012.041